Hillman et al[40] used whole-exome and cancer gene panel sequencing of 79 aGCTs, found truncating mutation of the histone-lysine N-methyltransferase 2D (KMT2D; also known as MLL2) was a recurrent somatic event in aGCTs. This evidence concerns the gene KMT2D and cancer.